Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hae Tha Mya"'
Autor:
Shien Wen Gan, Hui Lin Choong, Shilpa Surendran, Shu Hui Yeang, Heng Joo Ng, Cynthia C. Lim, Hui Ming Tay, Lai Heng Lee, Hae Tha Mya
Publikováno v:
International Journal of Hematology. 104:92-98
Increasing awareness and availability of tests for anti-PF4/heparin complex antibodies has raised concerns about indiscriminate testing and inappropriate diagnosis of heparin-induced thrombocytopenia. A retrospective review of HITS testing at a large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fb382572a8bbccecae338637861ebd
https://doi.org/10.1007/s12185-016-2013-3
https://doi.org/10.1007/s12185-016-2013-3
Publikováno v:
International Journal of Hematology. 105:3-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46fb921d6dfb898fbb6311312b7bc68
https://doi.org/10.1007/s12185-016-2103-2
https://doi.org/10.1007/s12185-016-2103-2
Autor:
Naoto Takahashi, V. S. Nadarajan, Yijun Ruan, Anbupalam Thalamuthu, Wing-Kin Sung, Xing Yi Woo, Hae Tha Mya, Sheila Soh, Xiaoan Ruan, Wen Chun Juan, Kazutoshi Isobe, Markus M. Nöthen, Wan-Teck Lim, John W.J. Huang, Hein Than, Yao Fei, L.Y. Yang, Chia-Tien Chang, Dianne Poh, Noan-Minh Chau, Axel M. Hillmer, Liang Piu Koh, Ai Leen Ang, Gee Fung How, Mei-Kim Ang, Yeow Tee Goh, Lay Cheng Lim, Tan Min Chin, Daniel Shao-Weng Tan, Wee Joo Chng, Balram Chowbay, Audrey S.M. Teo, Hiroyuki Mano, Ju Ee Seet, Niranjan Nagarajan, Quan Sing Ng, Shenli Zhang, Pramila N. Ariyaratne, Atif Shahab, Wan Ting Poh, Manabu Soda, Patrick Tan, Yasushi Yatabe, Kenichi Sawada, Vikrant Kumar, Ross A. Soo, Tien Yin Wong, Valere Cacheux-Rataboul, Charles Chuah, Eng Huat Tan, John Carson Allen, King Pan Ng, Wah Heng Lee, S. Tiong Ong, Tun Kiat Ko
Publikováno v:
Nature medicine. 18(4)
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small-cell lung cancer (EGFR NSCLC). However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f59fffa8f03bafce17db3a749469cb
https://pubmed.ncbi.nlm.nih.gov/25295933
https://pubmed.ncbi.nlm.nih.gov/25295933
Autor:
Irene Aires, Luis M Vaquero, José María Bastida, Consuelo del Cañizo, Marcos González, Alejandro Martin-Sancho, Noemi Puig, Abelardo Bárez, Domingo Bustos, Sandra Valle Herrero, Sara Alonso, José J. Pérez, María Jesús Garcia, Hae Tha Mya, Veronica D. Gonzalez, Carlos Aguilar, Agustin Díaz-Alvarez, María Belén Vidriales, Maria Diez Campelo
Publikováno v:
Blood. 126:1694-1694
Chronic myelomonocytic Leukemia (CMML) is a heterogeneous clonal disorder highly resistant to the few therapies that are available nowadays. There is increasing evidence to suggest that Programmed Death-1 (PD-1), and its major ligand Programmed Death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6840f1369458944eafc9f57722f7d71a
https://doi.org/10.1182/blood.v126.23.1694.1694
https://doi.org/10.1182/blood.v126.23.1694.1694
Autor:
Veronica D. Gonzalez, Alfonso Garcia-Coca, Agustin Díaz-Alvarez, Erik de Cabo, Luis M Vaquero, Alejandro Martin-Sancho, José J. Pérez, María Belén Vidriales, Patricia Fernðndez, Julio Dávila, Marcos González, Tomás Emilio Díaz González, Hae Tha Mya, Maria Diez Campelo, Ana Africa Martín López, José María Bastida, Noemi Puig, Domingo Bustos, Sandra Valle Herrero, Consuelo del Cañizo
Publikováno v:
Blood. 126:5248-5248
Chronic myelomonocytic leukemia (CMML) is a clonal disorder with a diagnostic challenge encountered frequently in routine hematology consultations, especially when few dysplastic features in bone marrow and/or no cytogenetics or molecular alterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7565b6ea178dfac323298aafed02ef18
https://doi.org/10.1182/blood.v126.23.5248.5248
https://doi.org/10.1182/blood.v126.23.5248.5248
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In The American Journal of Medicine August 2014 127(8):e7-e8
Autor:
Niranjan Nagarajan, Atif Shahab, Audrey S.M. Teo, John Carson Allen, Markus M. Nöthen, L.Y. Yang, Charles Chuah, Wah Heng Lee, Axel M. Hillmer, Liang Piu Koh, Tien Yin Wong, Ai Leen Ang, Yeow-Tee Goh, Gee Fung How, Lay Cheng Lim, Kenichi Sawada, Wee Joo Chng, Naoto Takahashi, King Pan Ng, Pramila N. Ariyaratne, Vikrant Kumar, Wing-Kin Sung, S. Tiong Ong, Weijie Huang, Yao Fei, Tun-Kiat Ko, Anbupalam Thalamuthu, Xiaoan Ruan, Wen Chun Juan, Wan Ting Poh, V. S. Nadarajan, Yijun Ruan, Valere Cacheux-Rataboul, Xing Yi Woo, Hae Tha Mya, Hein Than
Publikováno v:
Web of Science
Abstract 1666 The use of the tyrosine kinase inhibitor (TKI), imatinib (IM), to target the oncogenic BCR-ABL kinase has resulted in profound responses in patients with chronic phase (CP) chronic myelogenous leukemia (CML). However, a subset of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec1cdb94fc4c92df5f9271cc9936fcb
https://publons.com/wos-op/publon/7077172/
https://publons.com/wos-op/publon/7077172/
